SGMO earnings: a negative outcome, -8.1%

On March 13, 2024, Sangamo Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.1% in the window around the event. It had already run +13.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.